lactic acid has been researched along with imipenem, anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XG; Fu, FH; Gao, YB; Jiang, WL; Tian, JW; Zhu, HB | 1 |
| Mady, FM; Shaaban, MI; Shaker, MA | 1 |
2 other study(ies) available for lactic acid and imipenem, anhydrous
| Article | Year |
|---|---|
Paeoniflorin inhibits systemic inflammation and improves survival in experimental sepsis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Blood Urea Nitrogen; Bridged-Ring Compounds; Cecum; Cell Line; Clinical Enzyme Tests; DNA-Binding Proteins; Endotoxins; Glucosides; Hemodynamics; Imipenem; Inflammation; Inflammation Mediators; Intestine, Small; Lactic Acid; Liver; Lung; Macrophages; Male; Membrane Glycoproteins; Mice; Monoterpenes; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; Shock, Septic; Triggering Receptor Expressed on Myeloid Cells-1 | 2009 |
Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Infections; beta-Lactam Resistance; Biofilms; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Carriers; Drug Combinations; Drug Resistance, Multiple, Bacterial; Imipenem; Klebsiella pneumoniae; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa | 2017 |